Skip to main content

Role of in-house isolates in pharmaceutical quality control

Are you looking to improve your pharmaceutical quality control? Microbial contamination of pharmaceutical drugs adversely impacts their efficacy and quality presenting a significant patient risk.

It is imperative to monitor the quality of the processing environment with a robust and effective environmental monitoring (EM) programme.

This application note addresses the need to evaluate key sources of contamination to maintain an optimum level of pharmaceutical quality control.

This content was first published by European Pharmaceutical Review (EPR).

 

Download this application note by Dr Megha Bajaj, Global Solution Manager at bioMerieux, to discover more about:

  • The relevancy of in-house isolates in microbiological QC testing
  • The selection and implementation of in-house isolates
  • Common microorganisms isolated in pharma labs. Download this document to learn more.

DOWNLOAD THE WHITEPAPER

Filename
EPR App Note - Role of in-house isolates in pharmaceutical quality control - VDEF 2023.pdf
Size
1 MB
Format
application/pdf

RELATED CONTENT

BIOBALL 3 - Webinar Serie

WEBINAR

Read More

In this three-part webinar series, you’ll learn about BIOBALL® from industry experts.

Discover BIOBALL® best practices, applications in non-sterile product testing methods, our in-house Isolate service, and more.

Read More
BIOBALL Custom Service

PRODUCT

BIOBALL® Standardized Strains

BIOBALL® is a small water-soluble ball containing a precise number of microorganisms that delivers accuracy and precision, batch after batch.

Read More

SCIENTIFIC LIBRARY

Why Pharmaceutical Developers Use BIOBALL® 

The intellectual properties and proprietary methodologies used in making BIOBALL® redefine what was considered as quantitative microbiology and make it simple to get precise and accurate quantitative microbiological quality controls batch after batch.
Read More